Healthcare / Health Information ServicesNasdaqGS
$11.10
-0.32 (-2.80%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-25.6M · quality 78.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$302M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-30.0%
↓Gross Margin
75.3%
↑Debt/Equity
0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2025 · 2 años de histórico normalizado
Revenue CAGR
+91.5%
FCF CAGR
—
FCF margin
-60.1%
FCF / Net income
1.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $50.5M · net income $-29.6M · FCF $-30.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $50.5M | $50.5M | $27.2M | $13.8M |
| Net Income | $-29.6M | $-29.6M | $-24.3M | $-18.9M |
| EBITDA | $-27.9M | $-27.9M | $-22.8M | $-18.1M |
| EPS | -2.12 | -2.12 | -6.11 | -4.25 |
| Gross Margin | 75.3% | 75.3% | 73.8% | 71.9% |
| Operating Margin | -60.5% | -60.5% | -88.8% | -134.9% |
| Net Margin | -58.7% | -58.7% | -89.3% | -137.2% |
| Balance Sheet | ||||
| Debt/Equity | 0.18 | 0.18 | -0.24 | -0.25 |
| Current Ratio | 11.88 | 11.88 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $-30.3M | $-30.3M | $-25.6M | $-17.6M |
| Returns | ||||
| ROE | -30.0% | -30.0% | 34.3% | 41.0% |
| Valuation | ||||
| P/B | 1.60 | 1.60 | — | — |
| Growth & Yield | ||||
| Revenue Growth | 85.9% | 85.9% | 97.2% | — |
| EPS Growth | 65.2% | 65.2% | -43.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-6.11 → -2.12
Residual
-23.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.